Endothelial cells derived from patients' induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A

Hemophilia A (HA) is a bleeding disorder characterized by spontaneous and prolonged hemorrhage. The disease is caused by mutations in the coagulation factor 8 gene (F8) leading to factor VIII (FVIII) deficiency. Since FVIII is primarily produced in endothelial cells (ECs) in a non‐diseased human bei...

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Melanie, Gao, Kewa, Cortez‐Toledo, Elizabeth, Agu, Emmanuel, Hyllen, Alicia A., Conroy, Kelsey, Pan, Guangjin, Nolta, Jan A., Wang, Aijun, Zhou, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Pluripotent Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214661/
https://www.ncbi.nlm.nih.gov/pubmed/32162786
http://dx.doi.org/10.1002/sctm.19-0261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214661/
https://www.ncbi.nlm.nih.gov/pubmed/32162786
http://dx.doi.org/10.1002/sctm.19-0261

Ejemplares similares